Charlotte, NC
Psychedelic Therapy clinics in Charlotte
Psychedelic-assisted therapy in Charlotte sits mostly in the ketamine-assisted psychotherapy category, with some clinics also preparing for state-specific psilocybin frameworks. Psychiatric referrals for complex cases route through Atrium Health, Novant Health Presbyterian, and Levine Children's. Demand reflects a banking and healthcare-driven professional population.
Ketamine-assisted psychotherapy has the strongest US evidence base among psychedelic modalities. Psilocybin is not FDA approved and is only legally accessible within research or specific state programs. MDMA therapy is investigational. Clinics in Charlotte, North Carolina should be evaluated for therapist training, safety protocols, and honest evidence framing. North Carolina Medical Board scope on IV therapy and office procedures determines what can legally be offered.
With psychedelic therapy clinics on Regenerated.com in Charlotte, patients can compare clinician training, integration support, and legal framework before booking.
Mindpath Health Psychiatrists & Therapists
- Transcranial Magnetic Stimulation (TMS)
- Ketamine Therapy
- Psychedelic Therapy
Regulatory context
A note on North Carolina's psychedelic therapy rules.
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
-
HB 727 / Breakthrough Therapies Research Act (2023)
Proposed $5 million research grant for psilocybin and MDMA clinical studies at UNC institutions; pending. -
North Carolina Controlled Substances Act
Mirrors federal scheduling.
North Carolina enforces federal scheduling. The North Carolina Medical Board oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. North Carolina's CSRS PDMP requires controlled substance reporting. UNC and Duke operate federally authorized clinical trials.
Psychedelic Therapy in Charlotte, answered.
Explore related care